05:09 PM EDT, 05/28/2024 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said late Tuesday that Kevin Gorman will retire as chief executive officer on Oct. 11 and Kyle Gano, who is now chief business development and strategy officer, will succeed him in the role.

Gano will also join the board and Gorman will stay on the board, the company said.

Price: 138.80, Change: -1.68, Percent Change: -1.20